High levels of E6 and E7 oncoproteins, especially from high-risk HPV types, can downregulate the tumor suppressor RRAD, thereby inducing the NF-κB pathway (Gu et al., 2019), which leads to an elevated expression of A3 enzymes and increased tumor mutations. Here, NFKB1 is linked to neoplasm.